NY-AMERICAN-EXPRESS
16.9.2020 15:02:23 CEST | Business Wire | Press release
Today, American Express (NYSE: AXP) announced plans to expand two of its signature Centurion Lounges and introduced The Centurion Lounge Commitment, a set of new health and safety protocols and practices, which will be implemented in all Centurion Lounges as they reopen (some starting in early October). The Centurion Lounge at New York's LaGuardia Airport (LGA) will relocate to a larger location in the brand new Terminal B, and as previously announced, the current Centurion Lounge at Las Vegas’ McCarran International Airport (LAS), will be expanded and redesigned.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005291/en/
“The health, safety and comfort of our Card Members and colleagues remains our top priority as we look to expand and reopen our iconic Centurion Lounges around the world,” said Alexander Lee, Vice President Travel Experiences & Benefits. “We believe travel is core to our Card Members’ lifestyles, and like them, we look forward to the day when we can travel the world again - we’re excited to welcome them back into our Centurion Lounges soon.”
Upgrading the Centurion Lounge Experience at LAS and LGA:
Renovations to The Centurion Lounges at New York's LaGuardia Airport and Las Vegas’ McCarran International Airport will be completed in 2021. The expanded lounges will feature a suite of amenities for Card Members to enjoy when they resume traveling.
- The Centurion Lounge at LGA will double in size and relocate to a space post-security within the airport’s brand-new, state-of-the-art Terminal B. The new lounge will feature a family room, additional workspaces, private telephone rooms, and views of the New York City skyline.
- The footprint of the first-ever Centurion Lounge, opened at LAS in 2013, will be expanded from nearly 9,000 square feet to over 13,400 square feet. The newly designed lounge will feature additional multi-purpose areas, new private telephone rooms, newly designed reception and workspace areas and more.
American Express is also working towards opening its newest lounge locations later this year in New York’s John F. Kennedy Airport, London’s Heathrow Airport and Denver International Airport.
Creating a Healthy and Safe Environment with The Centurion Lounge Commitment:
While our Centurion Lounges continue to be closed due to COVID-19, American Express is introducing The Centurion Lounge Commitment to further support the health and safety of Card Members and colleagues when the lounges reopen. According to the Amex Trendex*, a trend report from American Express, nearly 2 in 3 consumers say either health and safety policies and procedures (39%) or flexibility (25%) is most important as they look to book future travel.
Card Members will experience new health and safety practices such as socially distanced seating, reduced capacity, increased cleaning frequency, requirements to wear a face covering when entering the lounge, served food instead of buffets, and more. For a contactless check-in experience, Card Members can download the American Express® App and use the Mobile Check-in Feature. These practices will be re-evaluated on an ongoing basis to take into account Card Members’ needs and the requirements of state and local governments and health authorities. Learn more here: thecenturionlounge.com/reopening .
While some may not be ready to travel today, the Amex Trendex* found over half (56%) of consumers who typically travel domestically anticipate feeling comfortable traveling to a domestic destination within six months. American Express is evaluating when to reopen its Centurion Lounge locations based on several factors, including local COVID-19 case prevalence, and will be taking a phased approach, location by location. The company expects to reopen the Centurion Lounges at Seattle-Tacoma airport and Philadelphia International airport on October 5, 2020, with more locations to follow.
*Amex Trendex
Methodology:
This online poll was conducted by Morning Consult poll between August 18-20, 2020 among a national sample of 2,000 general population travelers with a household income of at least $70K, and defined as adults (18+) who traveled by air at least once in 2019. Results from the survey have a margin of error of plus or minus 2 percentage points.
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress , instagram.com/americanexpress , linkedin.com/company/american-express , twitter.com/americanexpress , and youtube.com/americanexpress .
Key links to products, services and corporate responsibility information: charge and credit cards , business credit cards , travel services , gift cards , prepaid cards , merchant services , Accertify , InAuth , corporate card , business travel , and corporate responsibility .
ABOUT THE CENTURION LOUNGE
The Centurion Lounge is the signature lounge program within the broader American Express Global Lounge Collection , which includes access to American Express Centurion Lounges, international American Express lounges, Delta Sky Club® for Card Members flying on Delta, Priority PassTM Select Lounges upon enrollment, Airspace Lounges, MAG U.S. Escape Lounges and Plaza Premium Lounges--a total of more than 1,300 lounges across 140 countries and counting.
Access to The Centurion Lounge is complementary and exclusive for Platinum Card Members, Centurion Members and Delta SkyMiles® Reserve Card Members. Platinum Card Members may enter with up to two travel companions at no additional charge. Centurion Members may enter with their immediate family or up to two travel companions. Platinum Card and Centurion Members may purchase access to The Centurion Lounge for additional guests for $50 each guest. Delta SkyMiles® Reserve Card Members may bring up to two guests at a per-visit rate of $50 per person, per location.
Location: Global
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005291/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release
Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
